Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
Glassock
Richard J
RJ
D000419:Albuminuria / Q000209:etiology / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D003627:Data Interpretation, Statistical; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004338:Drug Combinations; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D007211:Indoles / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004338:Drug Combinations; D007211:Indoles; C052035:trandolapril; D014700:Verapamil